Home » Topics » Regulatory

Regulatory
RSS

Japan approves fluvoxamine maleate for social anxiety disorder

Oct. 14, 2005

Remicade approved in E.U. for moderate to severe plaque psoriasis

Oct. 7, 2005

European approval for Vasovist for magnetic resonance angiography

Oct. 5, 2005

GSK's Zefix approved in Japan for HBV-associated cirrhosis

Sep. 26, 2005

Remicade now approved in U.S. for ulcerative colitis

Sep. 20, 2005

Increlex approved for short stature caused by severe primary IGF-1 deficiency

Sep. 1, 2005

Actoplus Met approved for type 2 diabetes

Aug. 31, 2005

Taxotere approved for endometrial cancer in Japan

Aug. 24, 2005

Singulair approved for symptoms of perennial allergic rhinitis

Aug. 23, 2005

Diovan approved for high-risk heart attack survivors

Aug. 8, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...